If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...

The cost-efficient model dubbed Gemini 2.0 Flash-Lite comes as a successor to the Gemini 1.5 Flash while sticking to the same ...

The pharmaceutical company plans to cut $2 billion in annual expenses by the end of 2027 through “operational efficiencies ...

Willis Investment Counsel grew its holdings in shares of Exxon Mobil Co. (NYSE:XOM – Free Report) by 0.9% during the fourth ...

Google has released a whole new range of AI-powered research and interactions that simply can't be matched by DeepSeek or OpenAI.

Busy day at Google today: the company rolled out version 2.0 of its Gemini AI assistant (previously announced in December) ...

Gemini 2.0 Flash is the base model that powers the free version of Gemini. It replaces Gemini 1.5 Flash which was released ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

Google also released an experimental version of Gemini 2.0 Pro, the company’s flagship model with the best performance for ...

The S&P 500 index trades at a forward price/earnings ratio of 21.9. The U.S. large-cap benchmark stock index is weighted by market capitalization. The index's current forward P/E valuation is 18% ...

Google, Alphabet, GOOG CEO Sundar Pichai calls Gemini Flash AI models more efficient than DeepSeek R1 and V3 on 4Q earnings ...